Correlation between hybrid PSMA PET MRI and histopathology at radical prostatectomy

Correlation between hybrid PSMA PET MRI and histopathology at radical prostatectomy

Bibliographic Details
Main Authors:	G. Mehawed, A. Tariq, P. Saadat, A. Joshi, M. Roberts, M. Perera, H. Rhee, A. Yeates, I. Mckenzie, J. Munns, E. Chung, P. Heathcote, J. Preston, M. Lawson, S. Wood, S. Gustafson, K. Miles, I. Vela
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320328901

Similar Items

PSMA PET/CT to guide salvage treatment post prostatectomy: The IMPPORT trial
by: S. Koschel, et al.
Published: (2020-07-01)

The role of multiparametric MRI and 68-Ga-PSMA PET/MRI in determining the location of index tumor in radical prostatectomy specimen
by: U. Coşar, et al.
Published: (2020-07-01)

Imaging tumour thrombus of clear cell renal cell carcinoma: FDG PET or PSMA PET? Direct in vivo comparison of two technologies
by: Seyedehpariya Saadat, et al.
Published: (2018-01-01)

A positive PSMA PET/CT Predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy
by: L. Nocera, et al.
Published: (2020-10-01)

A positive PSMA PET/CT predicts more aggressive disease progression in patients with biochemical recurrence after radical prostatectomy
by: D. Robesti, et al.
Published: (2020-07-01)

Histopathologic Outcomes of Robotic Radical Prostatectomy
by: Vipul R. Patel, et al.
Published: (2006-01-01)

Detection of intraprostatic tumor localisation with 18-Fluorine Prostate-Specific Membrane Antigen (PSMA) PET/CT compared to radical prostatectomy specimens: Is PSMA-targeted biopsy feasible? the DeTeCT trial
by: Y.J.L. Bodar, et al.
Published: (2020-07-01)

Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
by: Ann-Kathrin Oehus, et al.
Published: (2020-04-01)

Local recurrence after radical prostatectomy and additive radiation – can PSMA-radioguided surgery prolong therapy-free survival?
by: S. Knipper, et al.
Published: (2020-07-01)

Role of 68Ga-PSMA PET/CT after radical prostatectomy in patients with biochemical recurrence: Results of a monocentric retrospective study
by: A. Pecoraro, et al.
Published: (2020-10-01)

Enzalutamide Enhances PSMA Expression of PSMA-Low Prostate Cancer
by: Magdalena Staniszewska, et al.
Published: (2021-07-01)

Retracted: Histopathological Correlation Between Prostatic Adenocarcinoma in Transrectal Ultrasound Guided Biopsies and Radical Prostatectomy Specimens
by: Mohammad Faisal, et al.
Published: (2020-01-01)

Role of 68GA-PSMA pet/ct after radical prostatectomy in patients with biochemical recurrence: Results of a monocentric retrospective study
by: A. Pecoraro
Published: (2020-10-01)

Biochemical persistence of prostate-specific antigen after robot-assisted laparoscopic radical prostatectomy: Tumor localizations using PSMA PET/CT imaging
by: D. Meijer, et al.
Published: (2020-11-01)

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
by: Nina-Sophie Schmidt-Hegemann, et al.
Published: (2018-03-01)

Prediction of Biochemical Recurrence After Radical Prostatectomy Based on Preoperative 68Ga-PSMA-11 PET/CT
by: Xuefeng Qiu, et al.
Published: (2021-09-01)

Determining the predictive value of a pre-operative negative PSMA PET/CT in candidates for radical prostatectomy and extended pelvic lymph node dissection
by: D. Meijer, et al.
Published: (2020-11-01)

Patients with biochemical recurrence after radical prostatectomy and local recurrence or negative PSMA PET/CT are excellent candidates for salvage radiotherapy to the prostatic fossa
by: H.B. Luiting, et al.
Published: (2020-07-01)

Biomechanical model-based deformable registration of MRI and histopathology for clinical prostatectomy
by: Navid Samavati, et al.
Published: (2011-01-01)

68Ga-PSMA PET/CT versus CT and bone scan for investigation of PSA failure post radical prostatectomy
by: Yuigi Yuminaga, et al.
Published: (2021-04-01)

Quantifying resection quality in radical prostatectomy through histopathologic scoring of positive surgical margins
by: R.F.M.S. Keller, et al.
Published: (2020-11-01)

Total Tumor Volume on18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with225 Ac-PSMA-I&T
by: Albert, N.L, et al.
Published: (2022)

Automated synthesis and quality control of [99mTc]Tc-PSMA for radioguided surgery (in a [68Ga]Ga-PSMA workflow)
by: Else A. Aalbersberg, et al.
Published: (2020-05-01)

PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy
by: Hui Wang, et al.
Published: (2021-08-01)

<sup>68</sup>Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
by: Finn Edler von Eyben, et al.
Published: (2021-03-01)

PSMA-PET/CT in Patients with Recurrent Clear Cell Renal Cell Carcinoma: Histopathological Correlations of Imaging Findings
by: Falk Gühne, et al.
Published: (2021-06-01)

PSMA expression by microvasculature of thyroid tumors – Potential implications for PSMA theranostics
by: Andrey Bychkov, et al.
Published: (2017-07-01)

Changes of Radiation Treatment Concept Based on 68Ga-PSMA-11-PET/CT in Early PSA-Recurrences After Radical Prostatectomy
by: Dirk Bottke, et al.
Published: (2021-06-01)

Histopathological Ratios to Predict Gleason Score Agreement between Biopsy and Radical Prostatectomy
by: Vincenzo Fiorentino, et al.
Published: (2021-12-01)

PSMA Theranostics: Review of the Current Status of PSMA-Targeted Imaging and Radioligand Therapy
by: Wallace Jones, et al.
Published: (2020-05-01)

Does biopsy approach affect histopathology grade concordance from biopsy to prostatectomy? An Australian analysis
by: L. Qu, et al.
Published: (2020-07-01)

Contemporary hardware for radical prostatectomy
by: M. I. Shkolnik, et al.
Published: (2020-02-01)

Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate Cancer
by: Wajahat Khatri, et al.
Published: (2021-04-01)

Pre-test 68Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy—validation of a prediction model
by: Pia Kraft, et al.
Published: (2020-02-01)

Salvage therapies for PSMA PET-positive nodal recurrent prostate cancer
by: A. Kretschmer, et al.
Published: (2020-07-01)

PSMA Theranostics: Science and Practice
by: Kgomotso Mokoala, et al.
Published: (2021-08-01)

Metal-Based PSMA Radioligands
by: Eleni Gourni, et al.
Published: (2017-03-01)

Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA
by: Yu Wang, et al.
Published: (2021-02-01)

Orbital and brain metastases on 68Ga-PSMA PET/CT in a patient with prostate carcinoma refractory to 177Lu-PSMA and 225Ac-PSMA therapy
by: Ashwin Singh Parihar, et al.
Published: (2021-01-01)

Best laser for prostatectomy in the year 2013
by: Pankaj N Maheshwari, et al.
Published: (2013-01-01)